Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of Antidepressants in Parkinson's Disease.

Trial Profile

Study of Antidepressants in Parkinson's Disease.

Phase of Trial: Phase III

Latest Information Update: 04 Jun 2015

At a glance

  • Drugs Paroxetine (Primary) ; Venlafaxine (Primary)
  • Indications Depressive disorders; Parkinson's disease
  • Focus Therapeutic Use
  • Acronyms SAD-PD
  • Most Recent Events

    • 01 Feb 2011 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.
    • 01 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Mar 2008 The expected completion date for this trial is May 2009 (February 2009 for final data collection date for primary outcome measure), according to ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top